A continuous delivery system of IL-1 receptor antagonist reduces angiogenesis and inhibits tumor development.
Bar D, Apte RN, Voronov E, Dinarello CA, Cohen S. A continuous delivery system of IL-1 receptor antagonist reduces angiogenesis and inhibits tumor development. FASEB J. 2004 Jan; 18(1):161-3.